OpenVSafe by OpenVAERS
Search V-safe

G9H-58401-80513

3 vaccinations 5 coded responses 26 check-ins 6 free-text entries 1 call case
Sex
Male
Age at first dose
05-11
ZIP prefix
222 / VA
Registered
2021-11-06
Relationship
Child or adolescent in my care
Guardian
FHX-31219-62662
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2489910 (opens in a new window) high 11 / 11 — 4 of 7 VAERS symptoms same dose (3) VA matches 2022-04-26 / 2022-09-04 / 2022-10-26
received the same day as the last call
case 1127884

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-11-05
    Dose 1 — Pfizer-BioNTech
  2. 2021-11-06
    Registered in v-safe
  3. 2021-11-06
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Fair · Site: Pain, Swelling · Headache
    Adult check-in
  4. 2021-11-08
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Fair · Site: Pain · None
    Adult check-in
  5. 2021-11-09
    Survey response — days 1–6 daily, dose 1, dependent
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Slightly swollen lymph nodes
    MedDRA releases: 2024-11 · check-in free text available
  6. 2021-11-11
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  7. 2021-11-12
    Health check-in — day 7, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  8. 2021-11-19
    Health check-in — day 14, dose 1, dependent
    Feeling: Good
    Adult check-in
  9. 2021-11-26
    Dose 2 — Pfizer-BioNTech
  10. 2021-11-27
    Survey response — days 1–6 daily, dose 2, dependent
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tiredness
    Free text: Swollen Lymph Nodes/armpit
    MedDRA releases: 2024-11 · check-in free text available
  11. 2021-11-28
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Diarrhea
    Free text: Sore lymph nodes (armpit)
    Adult check-in · check-in free text available
  12. 2021-11-29
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  13. 2021-11-30
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Site: Itching · Muscle or body aches, Diarrhea
    Adult check-in
  14. 2021-12-01
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Fair · Headache, Muscle or body aches
    Adult check-in
  15. 2021-12-06
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  16. 2021-12-10
    Health check-in — day 14, dose 2, dependent
    Feeling: Good
    Adult check-in
  17. 2021-12-19
    Health check-in — day 21, dose 2, dependent
    Feeling: Good
    Adult check-in
  18. 2021-12-24
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  19. 2022-01-07
    Health check-in — day 42, dose 2, dependent
    Feeling: Good
    Adult check-in
  20. 2022-02-25
  21. 2022-04-26
    Dose 3 — Pfizer-BioNTech
  22. 2022-04-26
    Health check-in — day 0, dose 3, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  23. 2022-04-27
    Survey response — days 1–6 daily, dose 3, dependent
    MedDRA: Oedema peripheral — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Fatigue or tiredness, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Swollen Armpit
    MedDRA releases: 2024-11 · check-in free text available
  24. 2022-04-28
    Survey response — days 1–6 daily, dose 3, dependent
    MedDRA: Oedema peripheral, Oropharyngeal pain — Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activities
    Free text: Swollen armpit, sore throat
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-05-03
    Health check-in — day 7, dose 3, dependent
    Feeling: Good · Headache
    Adult check-in
  26. 2022-05-10
    Health check-in — day 14, dose 3, dependent
    Feeling: Good
    Adult check-in
  27. 2022-05-17
    Health check-in — day 21, dose 3, dependent
    Feeling: Good
    Adult check-in
  28. 2022-07-26
  29. 2022-10-26
    Survey response — 6 months, dose 3, dependent
    MedDRA: COVID-19, Cough, Drug hypersensitivity, Dyspnoea, Fatigue, Oropharyngeal pain, Urticaria — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    Free text: COVID-19-related fatigue, sore throat, cough. Hives following Paxlovid. Difficulty breathing. Symptoms have resolved.
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-10-26
    Report sent to call center — 6 months, dose 3, dependent
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
  31. 2022-10-26
    Call successful
    Completed over the phone
  32. 2023-04-26

Vaccinations

DoseDateManufacturerCo-administered
12021-11-05Pfizer-BioNTech No
22021-11-26Pfizer-BioNTech No
32022-04-26Pfizer-BioNTech No

Call center

1 call center case

1 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 10 — days 1–6 daily, dose 1, dependent

2021-11-09

Systemic reaction (other): Slightly swollen lymph nodes

Release 10 — days 1–6 daily, dose 2, dependent

2021-11-27

Systemic reaction (other): Swollen Lymph Nodes/armpit

Release 11 — days 1–6 daily, dose 3, dependent

2022-04-27

Systemic reaction (other): Swollen Armpit

2022-04-28

Systemic reaction (other): Swollen armpit, sore throat

Release 12 — days 1–6 daily, dose 2, dependent

2021-11-28

Systemic reaction (other): Sore lymph nodes (armpit)

Release 12 — 6 months, dose 3, dependent

2022-10-26

Symptoms: COVID-19-related fatigue, sore throat, cough. Hives following Paxlovid. Difficulty breathing. Symptoms have resolved.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDCOVID-19 · · ✓
SDDrug hypersensitivity · · ✓
SDDyspnoea · · ✓
SDFatigue · · ✓
SDOropharyngeal pain · · ✓
SDUrticaria · · ✓
SROLymphadenopathy · · ✓
SROOedema peripheral · · ✓
SROOropharyngeal pain · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release